Vertex Pharmaceuticals target price raised to $620 from $600 by BMO
VRTX•BMO raised its target price for Vertex Pharmaceuticals to $620 from $600.
Related News
AEON Biopharma expects $6.2 million in gross proceeds from warrant exercises
AEON•
Ocean Capital Acquisition names Yiyan Li CEO and chair
OCAC•
Spruce Power publishes update to financial calendar
SPRU•
Pershing Square Inc: Jefferies cuts target price to $51 from $58
PS•
Cloudflare gains after J.P. Morgan upgrades to 'overweight'
NET•